These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 526874)

  • 1. Does prior dantrolene affect the in vitro diagnosis of malignant hyperthermia susceptibility?
    Nelson TE; Flewellen EH
    Can Anaesth Soc J; 1979 Nov; 26(6):484-8. PubMed ID: 526874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine malignant hyperthermia: effect of dantrolene sodium on in-vitro halothane-induced contraction of susceptible muscle.
    Anderson IL; Jones EW
    Anesthesiology; 1976 Jan; 44(1):57-61. PubMed ID: 1244776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle.
    Foster PS; Denborough MA
    Br J Anaesth; 1989 May; 62(5):566-72. PubMed ID: 2730830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on normal human skeletal muscle in relation to the pathopharmacology of malignant hyperpyrexia.
    Nelson TE; Denborough MA
    Clin Exp Pharmacol Physiol; 1977; 4(3):315-22. PubMed ID: 891045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dantrolene--in vitro studies in malignant hyperthermia susceptible (MHS) and normal skeletal muscle.
    Britt BA; Scott E; Frodis W; Clements MJ; Endrenyi L
    Can Anaesth Soc J; 1984 Mar; 31(2):130-54. PubMed ID: 6704779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
    Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
    Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.
    Ginz HF; Girard T; Censier K; Urwyler A
    Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect).
    Flewellen EH; Nelson TE; Bee DE
    Can Anaesth Soc J; 1980 Jan; 27(1):16-21. PubMed ID: 7353186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site of the muscle cell abnormality in swine susceptible to malignant hyperpyrexia.
    Okumura F; Crocker BD; Denborough MA
    Br J Anaesth; 1980 Apr; 52(4):377-83. PubMed ID: 7378237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for dantrolene vs. procainamide for treatment of malignant hyperthermia.
    Nelson TE; Flewellen EH
    Anesthesiology; 1979 Feb; 50(2):118-22. PubMed ID: 434484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro determination of susceptibility to malignant hyperthermia.
    Iaizzo PA; Lehmann-Horn F
    Muscle Nerve; 1989 Mar; 12(3):184-90. PubMed ID: 2725548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dantrolene does not block calcium pulse-induced calcium release from a putative calcium channel in sarcoplasmic reticulum from malignant hyperthermia and normal pig muscle.
    Nelson TE
    FEBS Lett; 1984 Feb; 167(1):123-30. PubMed ID: 6321231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A screening test for the malignant hyperpyrexia phenotype using suxamethonium-induced contracture of muscle treated with caffeine and its inhibition by dantrolene.
    Halsall PJ; Ellis FR
    Br J Anaesth; 1979 Aug; 51(8):753-6. PubMed ID: 497072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the calcium antagonist, TMB-8 on halothane and on caffeine contractures of malignant hyperthermia susceptible skeletal muscle.
    Williams JH; Holland M; Lee JC
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):387-90. PubMed ID: 2385762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle.
    Foster PS; Hopkinson KC; Denborough MA
    Clin Exp Pharmacol Physiol; 1989 Oct; 16(10):799-805. PubMed ID: 2612062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro diagnosis of malignant hyperpyrexia syndrome].
    Eldar I; Goldberg G; Glauber V; Perel A
    Harefuah; 1991 Dec; 121(12):499-502. PubMed ID: 1794753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temperature dependence of muscle function in malignant hyperpyrexia-susceptible swine.
    Sullivan JS; Denborough MA
    Br J Anaesth; 1981 Nov; 53(11):1217-22. PubMed ID: 7326167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine malignant hyperthermia: effects of temperature and extracellular calcium concentration on halothane-induced contracture of susceptible skeletal muscle.
    Nelson TE; Bedell DM; Jones EW
    Anesthesiology; 1975 Mar; 42(3):301-6. PubMed ID: 1115384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the "K-type" caffeine-halothane responder susceptible to malignant hyperthermia?
    Ellis FR; Halsall PJ; Hopkins PM
    Br J Anaesth; 1992 Nov; 69(5):468-70. PubMed ID: 1467078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of salbutamol on the in vitro muscle response to caffeine and halothane in malignant hyperthermia.
    Bendixen D; Ording H
    Acta Anaesthesiol Scand; 1990 Nov; 34(8):658-61. PubMed ID: 2275327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.